Welcome to the Novo Nordisk Inc. (NNI) Investigator-Sponsored Studies (ISS) Management system. This site allows you to submit an application to NNI for ISS support. The site is restricted to the submission of ISS grant requests only.
The requirements for submission of an ISS application includes but is not limited to a detailed full protocol and line-item budget (when applicable). Submission of an application does not constitute an agreement by NNI to support your ISS study. The final decision to support an ISS is made only after comprehensive review of your application has occurred by the Novo Nordisk teams on both the US (NNI) and Global level. For more information about our ISS program please refer to the resources below.
NNI ISS Program Overview: NNI Quick Reference Guide
NNI ISS Portal Navigation & Application Submission: NNI ISS Portal Reference Guide*Please note that all new ISS applications requesting semaglutide (e.g., injectables and oral formulation) are not being accepted. We will re-evaluate the situation Q1 2024 to determine when the process might re-open for submissions.